THELAST.NEWSBACK TO LATEST
WORLD · VERIFIED DEVELOPMENT

Peptide Drugs Pose Risks at High Doses, Experts Warn

WHY IT MATTERS

The expanding use of peptide therapies for weight loss and longevity raises safety and efficacy questions that could affect public health and medical practice.

What happened

Dr. Will Cole, a functional medicine specialist, cautioned that while GLP‑1 peptides can aid weight loss and metabolic health, excessive or continuous dosing may act like an “atomic bomb,” disrupting natural hunger signals and potentially fostering disordered eating. He highlighted that 93 % of U. S. adults are metabolically unhealthy and that lifestyle changes remain essential. Cole urged research into micro‑dosing and cyclic use, and called for clearer labeling and product purity to help patients and clinicians make informed choices. Despite concerns, he noted GLP‑1s may reduce inflammation, support autoimmune conditions, and improve gut health, but emphasized the need to balance benefits with safety.

PRIMARY SOURCES

Popular weight-loss drugs can become an ‘atomic bomb’ at high doses, doctor warns

Fox News · Discovery only; publisher copyright terms apply

CORRECTIONS & UPDATES

  1. Revision 1 · Initial ingestion · Sep 28, 2026, 11:46 AM
  2. Revision 2 · Source update detected · Sep 28, 2026, 11:46 AM
By THELAST.NEWS Editorial System · AI-assistedRevision 3Approved independent source